VF
CATX icon

Virtu Financial’s Perspective Therapeutics CATX Stock Holding History

Virtu Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62K Buy
+14,888
New +$62.9K ﹤0.01% 1255
2024
Q2 		– Sell
-11,576
Closed -$138K – 1361
2024
Q1 		$138K Buy
+11,576
New +$98.7K 0.01% 868
2023
Q4 		– Sell
-1,273
Closed -$3K – 1605
2023
Q3 		$3K Buy
+1,273
New +$5.94K ﹤0.01% 1169
2023
Q1 		– Sell
-6,700
Closed -$17K – 1575
2022
Q4 		$17K Buy
+6,700
New +$22.1K ﹤0.01% 1295
2022
Q3 		– Sell
-2,447
Closed -$8K – 1760
2022
Q2 		$8K Buy
+2,447
New +$7.47K ﹤0.01% 1440
2022
Q1 		– Sell
-4,084
Closed -$16K – 1542
2021
Q4 		$16K Sell
4,084
-582
-12% -$3.1K ﹤0.01% 1534
2021
Q3 		$29K Buy
4,666
+1,511
+48% +$10.3K ﹤0.01% 1353
2021
Q2 		$25K Sell
3,155
-14,619
-82% -$128K ﹤0.01% 1397
2021
Q1 		$194K Sell
17,774
-4,785
-21% -$72.3K 0.01% 1102
2020
Q4 		$102K Buy
22,559
+14,558
+182% +$64.3K 0.01% 1048
2020
Q3 		$47K Buy
+8,001
New +$52.1K 0.01% 828
2019
Q4 		$10K Sell
1,547
-5,215
-77% -$22.9K ﹤0.01% 1366
2019
Q3 		$22K Buy
+6,762
New +$24.5K ﹤0.01% 1280
2019
Q2 		– Sell
-1,574
Closed -$6K – 1480
2019
Q1 		$6K Sell
1,574
-3,776
-71% -$14.7K ﹤0.01% 1350
2018
Q4 		$16K Buy
5,350
+2,815
+111% +$12.1K ﹤0.01% 1394
2018
Q3 		$13K Sell
2,535
-676
-21% -$3.76K ﹤0.01% 1433
2018
Q2 		$14K Buy
+3,211
New +$14.9K ﹤0.01% 1887
2018
Q1 		– Sell
-5,491
Closed -$22K – 2003
2017
Q4 		$22K Buy
5,491
+1,229
+29% +$5.72K ﹤0.01% 2205
2017
Q3 		$22K Buy
+4,262
New +$23.9K ﹤0.01% 2334

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's CATX Position: Q1 2026 in Review

Virtu Financial opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 14,888 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CATX as recently as Q1 2024.

Virtu Financial first reported a position in CATX in Q3 2017 and has held it in 19 quarters since. The position peaked at $194K in Q1 2021. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Virtu Financial held 14,888 shares of Perspective Therapeutics worth $62K as of Q1 2026.
  • Perspective Therapeutics was a new Virtu Financial position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1255 holding.
  • Virtu Financial first reported a position in Perspective Therapeutics in Q3 2017 and has held it in 19 quarters since.
  • Virtu Financial's Perspective Therapeutics position peaked at $194K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.